US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stage

0.3754

+0.0000

Volume:- -

Turnover:- -

Market Cap:10.85M

PE:-0.11

High:0.3754

Open:0.3754

Low:0.3754

Close:0.3754

Loading ...

Overview Company News Filings

Errol Musk Visits Dubai: $MuskIt Token Takes Center Stage in the Future of Musk Institute

What Is Hedera? A Guide to the Open-Source Public Ledger

Alcon Inc. Reports Strong 2024 Performance and Sets Stage for Continued Innovation

Inside the Fight for Control of Servotronics: Paul Snyder's SAVE Servotronics Plan Takes Center Stage

AIM ImmunoTech Doses First Subject in Phase 2 of Late-Stage Pancreatic Cancer Study

MT Newswires Live

AIM Doses First New Subject in Phase 2 Study of Ampligen and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer

Bandwidth Releases 2025 State of Messaging Report: RCS, Deliverability and Consumer Trust Take Center Stage

Altimmune Expands Board Amid Late-Stage Drug Development

Maple Leaf Foods Reports Strong 2024 Results, Sets Stage for Transformative 2025

Metsera initiated as Early-Stage Biotech at Goldman Sachs

Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs

Ripple’s RLUSD Milestone Sets the Stage: How WallitIQ And Other Altcoins Could Benefit

Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company

Bitcoin Poised For Growth? Analyst Says 'One More Flush' Could Set Stage For Surge

Cautious Hold on Vertex Pharmaceuticals Amid Early-Stage Uncertainty of VX-522 Development

oOh!media Sets Stage for Strong Growth in 2025 with Strategic Adjustments

Sunstone Hotel Investors’ Strong 2024 Sets Stage for 2025

Supporters Stage Koplo Rally as Hasto Faces KPK Probe

What DOGE could gain by accessing your Social Security data

Parents Stage Rally, Demand Certainty of BIM 4th Batch Scholarship

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SSI/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","market":"US","secType":"STK","nameCN":"Stage","latestPrice":0.3754,"timestamp":1588968000000,"preClose":0.3754,"halted":3,"volume":0,"delay":0,"floatShares":20307519,"shares":28911336,"eps":-3.332056,"marketStatus":"Halted","change":0,"latestTime":"05-08 16:00:00 EDT","open":0.3754,"high":0.3754,"low":0.3754,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.332056,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":998884800000,"exchange":"NYSE","adjPreClose":0.3754,"dividendRate":0.133191,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","floatShares":20307519,"roa":"-3.54%","roe":"-44.60%","lyrEps":-3.1264,"shares":28911336,"dividePrice":0.05,"high":0.3754,"amplitude":0,"preClose":0.3754,"low":0.3754,"week52Low":0.27,"pbRate":"0.07","week52High":9.5,"institutionHeld":0.5253,"latestPrice":0.3754,"eps":-3.332056,"divideRate":0.133191,"volume":0,"delay":0,"ttmEps":-3.332056,"open":0.3754,"prevYearClose":8.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSI\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514852098","title":"Errol Musk Visits Dubai: $MuskIt Token Takes Center Stage in the Future of Musk Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2514852098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514852098?lang=en_us&edition=fundamental","pubTime":"2025-02-27 00:00","pubTimestamp":1740585603,"startTime":"0","endTime":"0","summary":"Dubai, United Arab Emirates, February 26th, 2025, Chainwire The MuskIt team was proud to host Errol Musk in Dubai for an exclusive four-day visit t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/errol-musk-visits-dubai-muskit-token-takes-center-stage-in-the-future-of-musk-institute?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/errol-musk-visits-dubai-muskit-token-takes-center-stage-in-the-future-of-musk-institute?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2514688537","title":"What Is Hedera? A Guide to the Open-Source Public Ledger","url":"https://stock-news.laohu8.com/highlight/detail?id=2514688537","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514688537?lang=en_us&edition=fundamental","pubTime":"2025-02-26 16:46","pubTimestamp":1740559613,"startTime":"0","endTime":"0","summary":"Hedera Hashgraph introduces a new approach to distributed ledger technology  with the potential to overcome limitations in existing networks. Specifically, it promises to tackle five critical pain points that have traditionally slowed down DLT’s mainstream acceptance and adoption. Hedera sets out to solve these with a high-speed, low-cost, and enterprise-grade network that delivers near-instant finality without compromising decentralization. This guide explores the ins and outs of Hedera Hashgraph, including how it works and what sets it apart from blockchain networks.Hedera Hashgraph is a high-speed distributed ledger offering secure, scalable, and low-cost transactions for various applications.Unlike blockchains, Hedera uses hashgraph consensus with gossip and virtual voting to ensure fast, fair, and efficient transactions.HBAR, Hedera’s native asset, is used for transaction fees, network security, staking, and powering decentralized applications.Hedera Hashgraph is a public distribu","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/04/bic_Hedera_HBAR_1-covers_neutral-1-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/04/bic_Hedera_HBAR_1-covers_neutral-1-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/learn/hedera-guide/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["ETH.USD.HKCC","SSI","BK4082","ETH.USD.CC","HSCS"],"gpt_icon":0},{"id":"2514047630","title":"Alcon Inc. Reports Strong 2024 Performance and Sets Stage for Continued Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2514047630","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514047630?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:01","pubTimestamp":1740520868,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Alcon ( ($CH:ALC) ). In 2024, Alcon Inc. demonstrated strong operational and financial performance, achieving a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alcon-inc-reports-strong-2024-performance-and-sets-stage-for-continued-innovation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alcon-inc-reports-strong-2024-performance-and-sets-stage-for-continued-innovation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","LU1804176565.USD","BK4198","LU2265009873.SGD","BK4534","ALC"],"gpt_icon":0},{"id":"2514201263","title":"Inside the Fight for Control of Servotronics: Paul Snyder's SAVE Servotronics Plan Takes Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2514201263","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514201263?lang=en_us&edition=fundamental","pubTime":"2025-02-26 01:17","pubTimestamp":1740503820,"startTime":"0","endTime":"0","summary":"Beaver Hollow Wellness proxy fight featured in The Buffalo News. BUFFALO, N.Y., Feb. 25, 2025 /PRNewswire/ -- The Buffalo News recently published an in-depth story on the proxy fight for control ofServotronics, Inc. , the Elma, New York-based manufacturer of high-performance servo valves for the aerospace industry. The battle pits Paul Snyder III, Servotronics' largest individual shareholder, against the current board, with Snyder championing his transformative SAVE Servotronics plan to revitalize the company and protect Western New York jobs.According to The Buffalo News, \"A dissident shareholder campaign aiming to win a majority on Servotronics' board involves some prominent Buffalo family names. Paul Snyder III, who is spearheading the effort, is Servotronics' largest individual shareholder, owning 15.2% of its shares. Charles 'Chris' Alfiero, the son of prominent Buffalo executive Sal Alfiero who now oversees the family's business and charitable ventures, is one of the group's nomi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inside-fight-control-servotronics-paul-171700233.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inside-fight-control-servotronics-paul-171700233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SSI","SAVE","BK4008","SVT","BK4500","BK4096"],"gpt_icon":0},{"id":"2514019457","title":"AIM ImmunoTech Doses First Subject in Phase 2 of Late-Stage Pancreatic Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019457","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514019457?lang=en_us&edition=fundamental","pubTime":"2025-02-26 00:14","pubTimestamp":1740500089,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech  said Tuesday it has dosed the first new subject in phase 2 of a phase 1b/2 clinical trial evaluating the company's Ampligen and AstraZeneca's  Imfinzi as a potential combination to treat late-stage pancreatic cancer.Phase 2 will also include various subjects who received the highest dose, AIM said.The company said that up to 25 patients are expected to be enrolled in the study's phase 2.AIM shares were down over 8% in recent trading.Price: 0.12, Change: -0.01, Percent Change: -8.44","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","AIM.AU","BK4588","BK4568","LU0889565916.HKD","LU2236285917.USD","LU1829250122.USD","AZN","SSI","LU2417539215.USD","AIM","BK7064","BK4139","LU2456880835.USD","BK4007","LU2462157665.USD","BK4557","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514091096","title":"AIM Doses First New Subject in Phase 2 Study of Ampligen and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091096","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091096?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:30","pubTimestamp":1740490200,"startTime":"0","endTime":"0","summary":"Several subjects who received the highest dose in Phase 1 will also be included in Phase 2. OCALA, Fla., Feb. 25, 2025  -- AIM ImmunoTech Inc.  today announced that the first new subject has been dosed in Phase 2 of the Phase 1b/2 clinical trial involving AIM’s Ampligen  and AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi  in the treatment of late-stage pancreatic cancer . Several subjects from Phase 1 who received the highest dose will also be included in Phase 2.AIM CEO Thomas K. Equels stated: “Unlike with many pancreatic cancer studies where accrual can be a major obstacle, we expect to continue to enroll subjects in Phase 2 of DURIPANC at a steady pace.”AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen , a dsRNA and highly selective TLR3 ago","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aim-doses-first-subject-phase-133000363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SSI","BK4139","BK4557","AIM"],"gpt_icon":0},{"id":"2514909970","title":"Bandwidth Releases 2025 State of Messaging Report: RCS, Deliverability and Consumer Trust Take Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2514909970","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514909970?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:12","pubTimestamp":1740489120,"startTime":"0","endTime":"0","summary":"Report is a must-read playbook for enterprises to maximize engagement,improve deliverability and future-proof their business text messaging strategies. RALEIGH, N.C., Feb. 25, 2025 /PRNewswire/ --Bandwidth Inc., a leading global enterprise cloud communications company, today announced the release of its highly anticipated 2025 State of Messaging Report, which reveals the key trends shaping business messaging for enterprises worldwide.As businesses navigate rising consumer expectations, evolving industry requirements and the emergence of next-gen messaging channels, Bandwidth's new report provides critical insights to maximize engagement, improve deliverability and future-proof messaging strategies.\"Messaging remains one of the most powerful channels for enterprise communications, but the landscape is shifting rapidly,\" said Tim Sherwood, Senior Vice President of Messaging and Mobility at Bandwidth. \"With Apple's adoption of RCS, along with global regulatory complexity and rising concer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bandwidth-releases-2025-state-messaging-131200200.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bandwidth-releases-2025-state-messaging-131200200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","IE00BGHQF631.EUR","LU0348723411.USD","BK4525","LU2506951958.HKD","BK4581","LU0950375773.USD","BAND","BK4560","BK4089","LU1599440770.SGD","SG9999015986.USD","IE0034235188.USD","LU2286300806.USD","SSI","LU1267930813.SGD","SG9999001424.SGD","LU0731783394.SGD","IE00B3T34201.USD","BK4533","LU0234570918.USD","LU0234572021.USD","LU1066051225.USD","LU1883839398.USD","RCS","STT","IE00BDGV0183.EUR","SG9999015978.USD","IE00B64PRP62.GBP","IE00BVYPNV92.GBP","LU1430594728.SGD","LU1506573853.SGD","CSCO","LU1880398471.USD","LU2237443895.HKD","IE00BFXG1179.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU0889566641.SGD","SG9999001440.SGD","LU1894683348.USD","SG9999015952.SGD","LU0203347892.USD","LU2237443978.SGD","IE00B3PB1722.GBP","IE00BSNM7G36.USD","LU0823417653.USD","LU0203345920.USD","LU2237443465.HKD","BK4550"],"gpt_icon":0},{"id":"2514656099","title":"Altimmune Expands Board Amid Late-Stage Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2514656099","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514656099?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:58","pubTimestamp":1740488314,"startTime":"0","endTime":"0","summary":"Altimmune ( ($ALT) ) has shared an update. On February 24, 2025, Altimmune, Inc. expanded its Board of Directors by appointing Teri Lawver and Jero...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/altimmune-expands-board-amid-late-stage-drug-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/altimmune-expands-board-amid-late-stage-drug-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2514060970","title":"Maple Leaf Foods Reports Strong 2024 Results, Sets Stage for Transformative 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060970?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:41","pubTimestamp":1740483685,"startTime":"0","endTime":"0","summary":"An announcement from Maple Leaf Foods ( ($TSE:MFI) ) is now available. Maple Leaf Foods reported a strong financial performance for the fourth quar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maple-leaf-foods-reports-strong-2024-results-sets-stage-for-transformative-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maple-leaf-foods-reports-strong-2024-results-sets-stage-for-transformative-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFI","BK4127","SSI"],"gpt_icon":0},{"id":"2514506511","title":"Metsera initiated as Early-Stage Biotech at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2514506511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514506511?lang=en_us&edition=fundamental","pubTime":"2025-02-25 17:31","pubTimestamp":1740475888,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Chris Shibutani initiated coverage of Metsera (MTSR) as an Early-Stage Biotech. Metsera is clinical-stage biopharmaceutical c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metsera-initiated-as-early-stage-biotech-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metsera-initiated-as-early-stage-biotech-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836914.USD","BK4516","LU2750360641.GBP","LU0096364046.USD","LU2471134952.CNY","LU2471134796.USD","LU0061475181.USD","LU2471134879.HKD","BK4585","IE0004086264.USD","LU2237438978.USD","IE00B19Z3B42.SGD","LU2750360997.AUD","LU1791807156.HKD","BK4127","BK4552","LU2237443895.HKD","LU2237443549.SGD","LU1868836757.USD","LU2237443622.USD","LU2471134523.USD","BK4504","BK4139","IE00B19Z3581.USD","LU1868837300.USD","MTSR","IE00BSNM7G36.USD","IE0034235188.USD","LU1868836591.USD","IE0002270589.USD","LU1868837136.USD","LU2237443382.USD","BK4588","BK4550","IE00BFXG1179.USD","SSI","LU2237443978.SGD","BK4533","LU0106831901.USD","LU2237443465.HKD","IE0004091025.USD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2514722057","title":"Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2514722057","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514722057?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:34","pubTimestamp":1740422062,"startTime":"0","endTime":"0","summary":"On Monday, Axsome Therapeutics, Inc. announced that the EMERGE Phase 3 trial of Symbravo in patients experiencing inadequate response to oral CGRP inhibitors  met its primary endpoint.Symbravo demonstrated statistically significantly greater migraine treatment response than oral CGRP inhibitors, as measured by the Migraine Treatment Optimization Questionnaire  .Also Read: Axsome’s AXS-05 In Alzheimer’s Agitation Could Be Billion Dollar Opportunity, Says Analyst. In the trial, Symbravo rapidly and substantially improved migraine pain and most bothersome symptoms.Pain freedom within 2 hours for most attacks was reported half the time or more by 47.9% of patients after treatment with Symbravo, compared to 1.0% of patients after treatment with oral CGRPs.The ability to quickly return to normal activities after taking their medication was reported half the time or more by 51.0% of patients after treatment with Symbravo, compared to 11.5% of patients after treatment with oral CGRPs.This arti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-says-symbravo-hits-primary-183422632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","AXSM","SSI","BK4585","BK4007"],"gpt_icon":0},{"id":"2514793617","title":"Ripple’s RLUSD Milestone Sets the Stage: How WallitIQ And Other Altcoins Could Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514793617","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514793617?lang=en_us&edition=fundamental","pubTime":"2025-02-25 00:46","pubTimestamp":1740415610,"startTime":"0","endTime":"0","summary":"Ripple’s RLUSD is making waves, establishing itself as a game-changer in the digital asset landscape. With adoption surging, this breakthrough paves the way for significant shifts across the altcoin m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67bca27c6ba7bc304cfdd513/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["SSI","XRP.USD.CC"],"gpt_icon":0},{"id":"2513726557","title":"Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726557","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726557?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:00","pubTimestamp":1740402000,"startTime":"0","endTime":"0","summary":"Leverages Celularity World-class Manufacturing CapabilitiesFLORHAM PARK, N.J., Feb.  24, 2025  (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3031099/0/en/Celularity-Enters-Strategic-Collaboration-Agreement-with-Clinical-Stage-Cell-Therapy-Company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BHPRN162.USD","IE00B1BXHZ80.USD","LU0170899867.USD","CMC","LU0882574139.USD","LU0149725797.USD","IE00BKVL7J92.USD","LU0267386448.USD","LU1363072403.SGD","IE00BZ1G4Q59.USD","SSI","BK4006","LU0971096721.USD"],"gpt_icon":0},{"id":"2513746277","title":"Bitcoin Poised For Growth? Analyst Says 'One More Flush' Could Set Stage For Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2513746277","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513746277?lang=en_us&edition=fundamental","pubTime":"2025-02-24 18:33","pubTimestamp":1740393217,"startTime":"0","endTime":"0","summary":"Cryptocurrency analyst James Van Straten shared his optimistic perspective on Bitcoin’s (CRYPTO: BTC) ongoing market consolidation on Saturday, describing it as “bullish.”","market":"us","thumbnail":"https://www.benzinga.com/files/images/story/2025/02/24/Bitcoins-Two-Possible-Scenarios.jpeg","type":0,"news_type":0,"thumbnails":["https://www.benzinga.com/files/images/story/2025/02/24/Bitcoins-Two-Possible-Scenarios.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/cryptocurrency/25/02/43907351/bitcoin-poised-for-growth-analyst-says-one-more-flush-could-set-stage-for-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"Benzinga","symbols":["BTC","BTC.USD.HKCC","BTC.USD.CC","BK4585","BK4588","BK4594","SSI","BK4601"],"gpt_icon":1},{"id":"2513627727","title":"Cautious Hold on Vertex Pharmaceuticals Amid Early-Stage Uncertainty of VX-522 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2513627727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513627727?lang=en_us&edition=fundamental","pubTime":"2025-02-24 09:16","pubTimestamp":1740359817,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Terence Flynn has maintained their neutral stance on VRTX stock, giving a Hold rating on February 20. Terence Flynn has give...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cautious-hold-on-vertex-pharmaceuticals-amid-early-stage-uncertainty-of-vx-522-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cautious-hold-on-vertex-pharmaceuticals-amid-early-stage-uncertainty-of-vx-522-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4567","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","LU2347655156.SGD","SSI","IE0009355771.USD","LU2133065610.SGD","LU0106831901.USD","LU1732800096.USD","LU2236285917.USD","IE00B4R5TH58.HKD","LU0256863811.USD","LU0823416689.USD","VRTX","LU0795875169.SGD","LU0106261372.USD","IE00BZ9MQY76.HKD","BK4533","BK4023","IE00BJJMRZ35.SGD","LU0225283273.USD","LU0320765992.SGD","LU0912757837.SGD","LU2111349929.HKD","IE00B19Z3B42.SGD","LU1074936037.SGD","LU2028103732.USD","LU1720051108.HKD","LU1989772840.SGD","LU0757428866.USD","IE00B19Z9P08.USD","LU1720051017.SGD","LU1585245621.USD","LU2462157665.USD","BK4127","LU1559883803.SGD","VERX","LU1732799900.SGD","IE0002270589.USD","LU2237438978.USD","LU1035775433.USD","LU0234570918.USD","LU2357305700.SGD","LU2362541273.HKD","LU0158827781.USD","BK4516","BK4588","BK4585","LU0795875086.SGD","LU1069344957.HKD"],"gpt_icon":0},{"id":"2513978765","title":"oOh!media Sets Stage for Strong Growth in 2025 with Strategic Adjustments","url":"https://stock-news.laohu8.com/highlight/detail?id=2513978765","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513978765?lang=en_us&edition=fundamental","pubTime":"2025-02-24 06:28","pubTimestamp":1740349698,"startTime":"0","endTime":"0","summary":"oOh media Ltd ( ($AU:OML) ) just unveiled an announcement. oOh!media Limited reported its financial results for 2024, showing a total revenue of $6...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oohmedia-sets-stage-for-strong-growth-in-2025-with-strategic-adjustments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oohmedia-sets-stage-for-strong-growth-in-2025-with-strategic-adjustments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2513632242","title":"Sunstone Hotel Investors’ Strong 2024 Sets Stage for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513632242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513632242?lang=en_us&edition=fundamental","pubTime":"2025-02-22 09:14","pubTimestamp":1740186843,"startTime":"0","endTime":"0","summary":"Sunstone Hotel Investors (($SHO)) has held its Q4 earnings call. Read on for the main highlights of the call. Sunstone Hotel Investors demonstrated...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sunstone-hotel-investors-strong-2024-sets-stage-for-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sunstone-hotel-investors-strong-2024-sets-stage-for-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","SHO-I","SHO","BK4218","BK4181"],"gpt_icon":0},{"id":"2512141150","title":"Supporters Stage Koplo Rally as Hasto Faces KPK Probe","url":"https://stock-news.laohu8.com/highlight/detail?id=2512141150","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512141150?lang=en_us&edition=fundamental","pubTime":"2025-02-20 17:33","pubTimestamp":1740044033,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Supporters of the Indonesian Democratic Party of Struggle  played and danced to dangdut koplo music as they waited for PDIP Secretary General Hasto Kristiyanto, who was undergoing questioning by the Corruption Eradication Commission .The crowd stated that they would wait for Hasto until Hasto's interrogationwas completed.\"We will wait until Pak Hasto comes out,\" said the orator, speaking from atop the command car in front of the KPK Red and White Building, South Jakarta, on Thursday, 20 February 2025.","market":"fut","thumbnail":"https://statik.tempo.co/data/2025/02/20/id_1378897/1378897_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/02/20/id_1378897/1378897_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1977810/supporters-stage-koplo-rally-as-hasto-faces-kpk-probe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2512059489","title":"What DOGE could gain by accessing your Social Security data","url":"https://stock-news.laohu8.com/highlight/detail?id=2512059489","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512059489?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:50","pubTimestamp":1739980202,"startTime":"0","endTime":"0","summary":"When people think of Social Security, they typically think of monthly benefits — for the roughly 69 million retirees, disabled workers, dependents and survivors who receive them today.But word that members of the Department of Government Efficiency  is seeking access to the Social Security Administration’s data systems should conjure up thoughts of data on hundreds of millions of people.It is data that runs “from cradle to grave,” said Kathleen Romig, who used to work at the SSA, first as a retirement policy analyst and more recently as a senior adviser in the Office of the Commissioner.DOGE’s request for IRS data systems access may pose risks to tax filers. As with the IRS data systems to which DOGE has also sought access, the SSA systems are old, complex, interconnected and run on programming language developed decades ago. If you make a change in one system, it could trip up another if you don’t know what you’re doing, said Romig, who now is director of Social Security and disabilit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2025/02/19/business/doge-social-security-personal-data/index.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2512126853","title":"Parents Stage Rally, Demand Certainty of BIM 4th Batch Scholarship","url":"https://stock-news.laohu8.com/highlight/detail?id=2512126853","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512126853?lang=en_us&edition=fundamental","pubTime":"2025-02-19 14:13","pubTimestamp":1739945626,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - The Association of Parents of Advanced Indonesia Scholarship  or BIM Batch 4 staged a rally in front of the Ministry of Higher Education, Science, and Technology in Jakarta on Wednesday, February 19, 2025. The rally demanded the government provide clarity regarding the continuity of the scholarship.Based on Tempo's observation on the ground, around 50 rally participants gathered in front of Building A at the office of the Ministry of Education, Culture, Research, and Technology. Later they moved to deliver their demands at Building F.The association's chairperson, Ihsandawi, stated that currently there is confusion regarding the certainty of continuing to study BIM 4 recipients. The parents of the scholarship recipients are concerned about whether the government will continue the scholarship amidst budget cuts based on Presidential Instruction Number 1 of 2025 regarding Budget Efficiency.","market":"nz","thumbnail":"https://statik.tempo.co/data/2025/02/19/id_1378564/1378564_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/02/19/id_1378564/1378564_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1977281/parents-stage-rally-demand-certainty-of-bim-4th-batch-scholarship","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["SSI","BK7095","BIM.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-21","symbol":"SSI","fiscalQuarterEnding":"2019/10","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1574312400000,"reportTimeType":"pre","actualEps":-0.15},{"date":"2019-08-22","symbol":"SSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/07","expectedEps":null,"defaultRemindTime":1566460800000,"name":null,"time":"Pre-Market","dateTimestamp":1566446400000,"actualEps":-0.6},{"market":"US","date":"2019-05-23","symbol":"SSI","fiscalQuarterEnding":"2019/04","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1558584000000,"reportTimeType":"pre","actualEps":-1.67},{"market":"US","date":"2019-03-07","symbol":"SSI","fiscalQuarterEnding":"2019/01","expectedEps":0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2018-12-03","symbol":"SSI","amount":0.05,"name":"Stage Stores Inc","currency":"USD","type":"dividend","dateTimestamp":1543813200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSI\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-08-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-11-27","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2018-03-05","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSI\",market:\"US\",delay:false,,,undefined,":{}}}